CLINICAL_TRIALS
research
· 2011-06-08
Clinical Trial Update: A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial [Phase 2]
Summary
This document describes a rollover study for subjects who completed participation in the VRX496-USA-05-002 Phase 2 trial for HIV infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VIRxSYS Corporation | Conditions: HIV Infections | Phase 2 | Status: UNKNOWN